Page last updated: 2024-11-08

pentylenetetrazole and Heart Failure

pentylenetetrazole has been researched along with Heart Failure in 1 studies

Pentylenetetrazole: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.
pentetrazol : An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.

Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
WOLLHEIM, E1
SASAMOTO, H1

Other Studies

1 other study available for pentylenetetrazole and Heart Failure

ArticleYear
[CARDIAC AND VASCULAR INSUFFICIENCY AND THEIR TREATMENT].
    Nihon Ishikai zasshi. Journal of the Japan Medical Association, 1963, Nov-01, Volume: 50

    Topics: Angiotensins; Blood Pressure; Blood Volume; Cardiovascular Diseases; Digitalis; Digitalis Glycosides

1963